Tumor uptake as a function of tumor mass: a mathematic model

Area of Science:

• Nuclear Medicine
• Radiopharmacology
• Oncology

Background:

• Accurate quantification of radiotracer uptake in tumors is essential for effective diagnosis and therapy.
• Tumor characteristics, such as mass and geometry, can influence tracer biodistribution.
• Understanding the relationship between tumor mass and tracer uptake is critical for dose calculations.

Purpose of the Study:

• To investigate the correlation between tumor uptake of various tracers and tumor mass.
• To determine the mathematical relationship governing tumor uptake as a function of tumor mass.
• To assess the impact of tumor size on radiation absorbed dose estimations.

Main Methods:

• Analyzed biodistribution data from 11 animal experiments using phospholipid vesicle, nonspecific, and specific monoclonal antibody tracers.
• Determined inverse correlation coefficients (u = B mA) between tumor uptake (u) and tumor mass (m).
• Compared experimental exponent (A) and intercept (B) values with theoretical models (spherical, cylindrical) and xenograft implantation sites.

Main Results:

• Demonstrated a consistent inverse correlation between tumor uptake and tumor mass across different tracers.
• Experimental exponents (A) ranged from -0.28 to -0.64 (mean -0.43), aligning with geometric tumor models.
• LS174T xenograft studies showed consistent exponents across different implantation sites, indicating stable tumor geometry.

Conclusions:

• Tumor uptake is significantly influenced by tumor mass, following a power-law relationship.
• Biodistribution data reporting should incorporate the variation of tumor uptake with mass.
• Radiation absorbed dose predictions are highly dependent on tumor size, particularly for lesions <10g.